Table 8.
Cancer | miRNA | Animal-human | Cell lines | Targets | Pathways | Function | Ref |
---|---|---|---|---|---|---|---|
Malignant Peripheral Nerve Sheath Tumor (MPNST) | miR-21 | 12 MPNSTs, 11 neurofibroma, 5 normal nerves | HS-Sch-2, YST-1, NMS-2 |
PDCD4 | – | Downregulation of miR-21 by targeting PDCD4 could induce cell apoptosis of MPNST cells. | (85) |
Glioblastoma (GBM) | miR-96 | – | U87-MG, T98G U251-MG, A172 |
PDCD4 | Upregulation of miR-96 by targeting PDCD4 could improve radioresistance in GBM cells. | (88) | |
GBM | miR-21 | 13 pairs of GBM and normal brain tissue samples |
SNB19, U251, U87, SF767 | PDCD4 | – | Downregulation of miR-21 could reduce proliferation, enhance apoptosis, and suppress anchorage-independent growth in glioblastoma-derived cell lines. | (86) |
Neuroblastoma (NB) | miR-21 | – | SK-N-SH, SH-SY5Y, BE2C, 293T |
PDCD4, PTEN | – | Downregulation of miR-21 by targeting PTEN/PDCD4 could result in SK-N-SH cell apoptosis and suppress proliferation in NB. | (87) |
Retinoblastoma | miR-181b | – | HXO-RB44, HUVECs | PDCD10, HIF-1α, GATA6 |
– | Upregulation of miR-181b which is induced by hypoxia could increase angiogenesis of retinoblastoma cells by regulating PDCD10 and GATA6. | (89) |